BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 32655269)

  • 1. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.
    Polk SL; Choi JW; McGettigan MJ; Rose T; Ahmed A; Kim J; Jiang K; Balagurunathan Y; Qi J; Farah PT; Rathi A; Permuth JB; Jeong D
    World J Gastroenterol; 2020 Jun; 26(24):3458-3471. PubMed ID: 32655269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics model versus 2017 revised international consensus guidelines for predicting malignant intraductal papillary mucinous neoplasms.
    Lee DY; Shin J; Kim S; Baek SE; Lee S; Son NH; Park MS
    Eur Radiol; 2024 Feb; 34(2):1222-1231. PubMed ID: 37615762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of magnetic resonance image for malignant intraductal papillary mucinous neoplasms: the importance of size of enhancing mural nodule within cyst.
    Hong SB; Lee NK; Kim S; Seo HI; Park YM; Noh BG; Kim DU; Han SY; Kim TU
    Jpn J Radiol; 2022 Dec; 40(12):1282-1289. PubMed ID: 35781178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
    Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
    Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms.
    Permuth JB; Choi J; Balarunathan Y; Kim J; Chen DT; Chen L; Orcutt S; Doepker MP; Gage K; Zhang G; Latifi K; Hoffe S; Jiang K; Coppola D; Centeno BA; Magliocco A; Li Q; Trevino J; Merchant N; Gillies R; Malafa M;
    Oncotarget; 2016 Dec; 7(52):85785-85797. PubMed ID: 27589689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
    Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
    Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
    Roch AM; Barron MR; Tann M; Sandrasegar K; Hannaford KN; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2015 Jul; 221(1):48-56. PubMed ID: 26095551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Pedrazzoli S; Sperti C; Pasquali C; Bissoli S; Chierichetti F
    Ann Surg; 2011 Dec; 254(6):971-6. PubMed ID: 22076067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas.
    Chakraborty J; Midya A; Gazit L; Attiyeh M; Langdon-Embry L; Allen PJ; Do RKG; Simpson AL
    Med Phys; 2018 Nov; 45(11):5019-5029. PubMed ID: 30176047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.
    Kim MC; Kim JH; Jeon SK; Kang HJ
    PLoS One; 2024; 19(4):e0298278. PubMed ID: 38683769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
    Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
    Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining Malignant Potential of Intraductal Papillary Mucinous Neoplasm of the Pancreas: CT versus MRI by Using Revised 2017 International Consensus Guidelines.
    Lee JE; Choi SY; Min JH; Yi BH; Lee MH; Kim SS; Hwang JA; Kim JH
    Radiology; 2019 Oct; 293(1):134-143. PubMed ID: 31478800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative imaging to evaluate malignant potential of IPMNs.
    Hanania AN; Bantis LE; Feng Z; Wang H; Tamm EP; Katz MH; Maitra A; Koay EJ
    Oncotarget; 2016 Dec; 7(52):85776-85784. PubMed ID: 27588410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
    Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
    Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
    Min JH; Kim YK; Kim SK; Kim H; Ahn S
    Eur Radiol; 2021 Jul; 31(7):4774-4784. PubMed ID: 33409798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT.
    Chai L; Zhu N; Wang Q; Wang T; Chai W
    Acad Radiol; 2021 May; 28(5):679-686. PubMed ID: 32591278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas using MR findings and texture analysis.
    Jeon SK; Kim JH; Yoo J; Kim JE; Park SJ; Han JK
    Eur Radiol; 2021 May; 31(5):3394-3404. PubMed ID: 33140171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.